India’s probiotics market doubles in 5 years, hits Rs 2,070 cr in 2025
India's probiotics market has experienced a substantial annual growth rate of 22% as of May, effectively doubling in value from ₹1,016 crore in 2021 to ₹2,070 crore by 2025, according to PharmaTrac. This rapid growth is propelled largely by major pharmaceutical companies such as Sun Pharma and Zydus, with established brands maintaining a significant market presence.
The demand for probiotics in India is driven by increasing consumer awareness of health benefits, particularly in improving gut health and boosting immunity. Probiotics have become a crucial component in combating intestinal disorders and enhancing digestive health.
Despite the broadening market, new product launches have generated modest revenues of approximately ₹49 crore. The sector is predominantly led by probiotic drug sales, although dairy products like those offered by Amul and Mother Dairy are also central to market growth.
The market's dramatic expansion is evidenced by a compound annual growth rate (CAGR) of 19% over the past five years. As it stands, probiotics sales continue to rise with companies such as Amul claiming to distribute three million litres of probiotic buttermilk daily across India.
Notably, probiotics have garnered the attention of both investors and startups, with The Good Bug and WellBeing Nutrition drawing investment interest for their innovations in the space. Despite this growth, experts caution against unwarranted use of probiotics, emphasizing their effectiveness only in specific health contexts.
